|
Personal Data (기본정보) |
|
||
|
Name |
Kyung Pyo Kang |
||
|
Position |
Professor |
||
|
Affiliation |
Departments of Medical Science and Internal Medicine (Nephrology) Jeonbuk National University Medical School, Jeonju, Jeonbuk, Korea |
||
|
Phone |
(+82) 063-250-2361 |
||
|
|
kpkang@jbnu.ac.kr |
||
|
Homepage |
|
||
|
Education (학력) |
|||
|
Ph.D. |
(2005) |
Jeonbuk National University Graduate School, Jeonju, Jeonbuk, Korea |
|
|
M.S. |
(2003) |
Jeonbuk National University Graduate School, Jeonju, Jeonbuk, Korea |
|
|
M.D. |
(1996) |
Jeonbuk National University Medical School, Jeonju, Jeonbuk, Korea |
|
|
Professional Experience (경력) |
|||
|
2016.10.~ |
Professor, Department of Internal Medicine, Jeonbuk National University Medical School, Jeonju, Korea |
||
|
2016.07.~ |
Chief, Division of Nephrology, Department of Internal Medicine, Jeonbuk National University Hospital, Jeonju, Korea |
||
|
2014~2015 |
Visiting Associate professor, Department of Medicine, Yale University School of Medicine |
||
|
2011~2016 |
Associate professor, Department of Internal Medicine, Jeonbuk National University Medical School, Jeonju, Korea |
||
|
2007~2011 |
Assistant Professor, Department of Internal Medicine, Jeonbuk National University Medical School, Jeonju, Korea |
||
|
2005~2007 |
Clinical Instructor, Division of Nephrology, Department of Internal Medicine, Jeonbuk National University Hospital, Jeonju, Republic of Korea |
||
|
2004~2005 |
Clinical fellowship, Division of Nephrology, Department of Internal Medicine, Jeonbuk National University Hospital, Jeonju, Korea |
||
|
2000~2004 |
Residency, Department of Internal Medicine, Jeonbuk National University Hospital, Jeonju, Korea |
||
|
1997~2000 |
Army surgeons, Korea Army Infantry School, Korea |
||
|
1996~1997 |
Internship, Asan Medical Center, Seoul, Korea |
||
|
Research Interests (연구분야) |
|||
|
- Acute kidney injury and chronic kidney disease |
|||
|
- Glomerulonephritis and immune system |
|||
|
- Inflammation |
|||
|
- Kidney fibrosis |
|||
|
Representative Publications (대표적 연구업적) |
|||
|
1. Jin J, Wang T, Park W, Li W, Kim W, Park SK, Kang KP. Inhibition of YAP by verteporfin ameliorates unilateral ureteral obstruction-induced renal tubulointerstitial inflammation and fibrosis. Int J Mol Sci 2020 Oct 31; 21(21):8184. doi: 10.3390/ijms21218184 |
|||
|
2. Quan Y, Park W, Jin J, Kim W, Park SK, Kang KP. Sirtuin 3 activation by Honokiol decreases unilateral ureteral obstruction-induced renal inflammation and fibrosis via regulation of mitochondrial dynamics and the renal NF-κB-TGF-β1/Smad signaling pathway. Int J Mol Sci 2020 Jan8; 21(2):402. doi: 10.3390/ijms21020402 |
|||
|
3. Kim D, Park W, Lee S, Kim W, Park SK, Kang KP. Absence of Sirt3 aggravates cisplatin nephrotoxicity via enhanced renal tubular apoptosis and inflammation. Mol Med Rep. 2018 Oct;18(4):3665-3672 |
|||
|
4. Nguyễn-Thanh T, Kim D, Lee S, Kim W, Park SK, Kang KP. Inhibition of histone deacetylase 1 ameliorates renal tubulointerstitial fibrosis via modulation of inflammation and extracellular matrix gene transcription in mice. Int J Mol Med. 2018 Jan;41(1):95-106 |
|||
|
5. Lee AS, Jung YJ, Thanh TN, Lee S, Kim W, Kang KP, Park SK. Paricalcitol attenuates lipopolysaccharide-induced myocardial inflammation by regulating the NF-κB signaling pathway. Int J Mol Med. 2016 Apr;37(4):1023-9 |
|||
|
6. Kim D, Lee AS, Jung YJ, Yang KH, Lee S, Park SK, Kim W, Kang KP. Tamoxifen ameliorates renal tubulointerstitial fibrosis by modulation of estrogen receptor α-mediated transforming growth factor-β1/Smad signaling pathway. Nephrol Dial Transplant. 2014 Nov;29(11):2043-53 |
|||
|
7. Kang KP, Lee JE, Lee AS, Jung YJ, Kim D, Lee S, Hwang HP, Kim W, Park SK. Effect of gender differences on the regulation of renal ischemia-reperfusion-induced inflammation in mice. Mol Med Rep 2014 9(6):2061-8 |
|||
|
8. Kim D, Lee JE, Jung YJ, Lee AS, Lee S, Park SK, Kim SH, Park BH, Kim W, Kang KP. Metformin decreases high-fat diet-induced renal injury by regulating the expression of adipokines and the renal AMP-activated protein kinase/acetyl-CoA carboxylase pathway in mice. Int J Mol Med. 2013;32(6):1293-302 |
|||
|
9. Lee JE, Lee AS, Kim DH, Jung YJ, Lee S, Park BH, Lee SH, Park SK, Kim W, Kang KP. Janex-1, a JAK3 inhibitor, ameliorates tumor necrosis factor-α-induced expression of cell adhesion molecules and improves myocardial vascular permeability in endotoxemic mice. Int J Mol Med. 2012;29(5):864-870 |
|||
|
10. Kang KP, Park SK, Kim DH, Sung MJ, Jung YJ, Lee AS, Lee JE, Ramkumar KM, Lee S, Park MH, Roh SG, Kim W. Luteolin ameliorates cisplatin-induced acute kidney injury in mice by regulation of p53-dependent renal tubular apoptosis. Nephrol Dial Transplant 2011;26(3):814-822 |
|||
|
11. Kang KP, Kim DH, Jung YJ, Lee AS, Lee S, Lee SY, Jang KY, Sung MJ, Park SK, Kim W. Alpha-lipoic acid attenuates cisplatin-induced acute kidney injury in mice by suppressing renal inflammation. Nephrol Dial Transplant 2009 Oct;24(10):3012-20 |
|||